Deadly Drug Tianeptine 'Significant Risk' in US

🎙️ Voice is AI-generated. Inconsistencies may occur.

U.S. Customs and Border Protection (CBP) officers have seized a shipment of a "deadly, addictive and illegal substance" in Cincinnati that was worth over $246,000, sparking warnings from U.S. health officials.

According to official reports, 12 pounds of the dangerous substance were confiscated on January 26 for violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The intercepted shipment had originated in Hong Kong and was heading towards Houston, Texas, CBP officers reported.

The substance in question is tianeptine, an unapproved drug with dangerous side effects. According to the Food and Drug Administration (FDA), some companies in the U.S. are illegally marketing and selling tianeptine products to consumers with claims that it improves brain function and treats anxiety and depression, among other conditions.

Poison control centers have reported a dramatic rise in tianeptine side effects: while only 11 cases were reported nationwide between 2000 and 2013, 151 cases were reported across the county in 2020 alone, the FDA reported in 2022.

Tianeptine seizure
The seized tianeptine shipment is seen. U.S. Customs and Border Protection (CBP) officers screen border crossers as they arrive in California. CBP officers have seized a shipment of a "deadly, addictive and illegal substance" in... Jerry Glaser/U.S. Customs and Border Protection

According to CBP officers, the FDA is aware of an online tianeptine trade in the U.S. where the drug is usually sold in tablet or powder form.

"The FDA is especially concerned about the illegal importation of unsafe drugs like tianeptine which has been shown to pose a significant risk to patients and consumers," Dan Solis, assistant commissioner for import operations, said in a statement. "FDA supports CBP's efforts in protecting the nation's border through our cooperative partnerships and enforcement actions."

While the drug has been approved in other countries to treat anxiety and depression, it is usually accompanied by restricted prescriptions and a warning of possible addiction. The prescribed doses are also very small. "Medical journals and reports to the FDA suggest that adverse events may occur when tianeptine is taken at doses higher than the doses prescribed in the countries where the drug has been approved," the FDA states on its website.

Newsweek reached out to the FDA via email for comment.

People with a history of opioid use disorder or dependence may be at particular risk of abusing tianeptine, the FDA also warned.

Among the side effects reported from using this medication—either on its own or in combination with other drugs like antidepressants and anti-anxiety medication—are a rapid heartbeat, high blood pressure, nausea and vomiting, slowed or stopped breathing, coma and even death.

"CBP is responsible for ensuring that all goods entering and exiting the United States do so in accordance with all applicable U.S. laws and regulations. Our officers and specialists in Cincinnati consistently showcase their quality training and commitment to the CBP mission. They are exceptional at what they do and are part of the best frontline defense in the world," LaFonda D. Sutton-Burke, director of field operations for CBP's Chicago Field Office, said in a statement.

Is there a health problem that's worrying you? Do you have a question about tianeptine? Let us know via health@newsweek.com. We can ask experts for advice, and your story could be featured on Newsweek.

About the writer

Pandora Dewan is a Senior Science Reporter at Newsweek based in London, UK. Her focus is reporting on science, health and technology. Pandora joined Newsweek in 2022 and previously worked as the Head of Content for the climate change education start-up, ClimateScience and as a Freelance writer for content creators such as Dr. Karan Rajan and Thoughty2. She is a graduate in Biological Sciences from the University of Oxford. Languages: English. You can get in touch with Pandora by emailing p.dewan@newsweek.com or on Twitter @dewanpandora.


Pandora Dewan is a Senior Science Reporter at Newsweek based in London, UK. Her focus is reporting on science, health ... Read more